Statins have been linked to tinnitus but not shown to cause it: a study of 90,271 people with high cholesterol found statin users had 1.36 times the odds of tinnitus, with simvastatin highest and fluvastatin not significant.
Statins deserve their own look, separate from ototoxic medications generally, because this large analysis gives unusually specific numbers — including differences between individual statins that are worth knowing if you're on one.
What the largest recent study found
A retrospective cohort study, published online in 2025, used the National Institutes of Health's "All of Us" database — a research program representing over 710,000 US participants — to examine 90,271 patients with hyperlipidemia (high cholesterol). The analysis found statin use was associated with higher odds of both sensorineural hearing loss (odds ratio 1.60) and tinnitus (odds ratio 1.36) compared to non-use. The model took account of aspirin use, high blood pressure, diabetes, age, race and sex.
Not all statins showed the same association
The study's most practically useful finding is that individual statins didn't behave uniformly. Simvastatin showed the strongest association with both hearing loss (odds ratio 1.56) and tinnitus (odds ratio 1.50). Atorvastatin — the most widely prescribed statin — showed a more moderate association (hearing loss 1.27, tinnitus 1.21). Fluvastatin showed the weakest association with hearing loss (1.15) and no statistically significant association with tinnitus at all (1.02, not significant). This kind of drug-by-drug breakdown is exactly the detail that's easy to lose in a general "statins and tinnitus" search, and it's the most actionable part of this research.
Why this doesn't mean statins definitely cause tinnitus
This was an observational cohort study, not a randomized controlled trial — a design that cannot establish causation, and residual confounding is a real concern. People prescribed statins already have cardiovascular risk factors (high cholesterol, often blood pressure issues, sometimes diabetes) that are independently associated with tinnitus, as the article on cholesterol, atherosclerosis and tinnitus sets out. The analysis adjusted for some of these, but adjustment cannot remove what was not measured, and some of the observed association could reflect the underlying condition statins are prescribed for, not the medication itself. That said, a sample of over 90,000 people, broken down drug by drug, is a meaningfully stronger signal than a handful of case reports.
A note on conflicting older research
It's worth being upfront that the literature here isn't unanimous. Other, smaller studies — including one hospital-based study specifically in diabetic patients — found most statins associated with reduced risk of hearing loss or tinnitus, with only fluvastatin and pravastatin as exceptions. This kind of contradiction between studies is common in observational pharmacoepidemiology and is part of why the All of Us analysis, with its much larger sample, is treated here as the more weight-bearing source — not because older, smaller findings are wrong, but because they're more susceptible to the specific population studied.
What this means practically
- Statins remain, overall, medications with strong evidence for reducing cardiovascular risk — this isn't a reason to stop one without talking to your doctor, given the more immediate risks of untreated high cholesterol
- If you started a statin and noticed new tinnitus afterward, that timing is worth mentioning specifically to your prescriber — the drug-specific differences found here (simvastatin showing the strongest association, fluvastatin the weakest) are relevant context for whether an alternative is reasonable
- This is an association, not proven causation — don't assume a statin is the cause without ruling out the more common causes of tinnitus first
- Never stop a prescribed statin abruptly on your own — any change should go through the prescribing physician, weighing the cardiovascular benefit — see the article on tinnitus and blood pressure — against this observational signal